viewInspiration Healthcare

Inspiration Healthcare neonatal technology granted European patent

The protection covers Project WAVE, which uses a technology acquired under licence last year from an unnamed “major US west coast university”

Inspiration Healthcare -

Inspiration Healthcare Group PLC (LON:IHC) said a respiratory device used in neonatal intensive care can now be validated across the EU after being granted a European patent.

The protection covers Project WAVE, which uses a technology acquired under licence last year from an unnamed “major US West Coast university”.

WAVE has already secured US Patent Office sign-off, while the UK Medicines and Healthcare Products Regulatory Agency has approved it for clinical testing.

This will take place in the new year at the Trevor Mann Baby Unit, Brighton & Sussex University Hospital.

In a statement, Inspiration chief executive Neil Campbell said: "As we continue to move forward in the development of Project WAVE this is another milestone passed and one which both protects our IP and the investment we have made to ensure that this technology soon becomes adopted in hospitals, and we remain confident that once this happens, we will begin to see improved medical outcomes using this novel technology.”

Quick facts: Inspiration Healthcare

Price: 97 GBX

Market: AIM
Market Cap: £66.08 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Inspiration Healthcare named herein, including the promotion by the Company of Inspiration Healthcare in any Content on the Site, the Company...


Inspiration Healthcare Group says 'business is growing, its profitable......

Inspiration Healthcare Group PLC (LON:IHC) Neil Campbell talks to Proactive London about achieving a record turnover in the year to January 31, with revenues anticipated to surge 52% to £36.8mln. Campbell talks through the integration of SLE, Viomedex and the 'one-time' ventilator orders...

5 days, 18 hours ago

2 min read